O
Oui Health
Developing prescription digital therapeutics to save lives
About Oui Health
Oui Therapeutics is a digital therapeutics company that has developed a prescription-based mobile application, Aviva, to aid individuals who have experienced a suicidal crisis. The application is designed to be a directed and personalized program to help users manage distressing thoughts and is based on clinically trialed science.
Read full description
The company operates in the behavioral healthcare market, with a specific focus on suicide prevention. Its business model is centered around the development and distribution of FDA-regulated digital therapeutics. The primary clients for Oui Therapeutics are payers within the healthcare ecosystem, such as health insurers. By providing a scalable and accessible solution, the company aims to address the significant challenge of suicide, a highly misunderstood public health issue.
Founded in 2018, the New Haven-based company has reached the Series B funding stage, backed by a team of experts in digital therapy and suicide prevention. The company's approach is to combine scientific research with technology to create life-saving interventions for at-risk populations.
Latest news
Press, funding announcements and product moves mentioning Oui Health.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Aug 2022 | $26M | $104M | CVS Health · First Round Capital | ↗ |
| SEED✓Equity / VC | Jan 2019 | — | — | Flare Capital Partners | — |
Growth signals
Latest recorded traffic for Oui Health is 1.4K monthly website visits, up 366.7% over the last three months. Oui Health's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Flare Capital Partners
Series A2 investors entered at this stage
CVS Health
First Round Capital
Other known investors1 additional known investor
Yale University School of Medicine
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Oui Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Oui Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.